General Information of Drug (ID: DMKRZ0R)

Drug Name
LX1004 Drug Info
Indication
Disease Entry ICD 11 Status REF
CLN2 Batten disease 5C56 Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DMKRZ0R

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cerliponase Alfa DM0HAC8 Neuronal ceroid lipofuscinosis 5C56.1 Approved [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tripeptidyl-peptidase I (TPP1) TTOVYPT TPP1_HUMAN Not Available [1]

References

1 Clinical pipeline report, company report or official report of Lexeo Therapeutics
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.